GeneReach Biotechnology Corp. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 45.92 million compared to TWD 68.22 million a year ago.

Revenue was TWD 45.91 million compared to TWD 68.19 million a year ago. Net loss was TWD 20.26 million compared to TWD 37.31 million a year ago. Basic loss per share from continuing operations was TWD 0.35 compared to TWD 0.65 a year ago.

Diluted loss per share from continuing operations was TWD 0.35 compared to TWD 0.65 a year ago.